MultiCell Technologies Inc (MCET)

[Mcetdreamer]

Non believers, over 1,000,000,000 shares have been sold recently and a 1/2 billion of that was in one day.


1)
Multicell Technology Inc still has at least 3 Patented products being sold by other companies. ADCETRIS® classic Hodgkin's Lymphoma and KADCYLA BREAST DRUG

2)
Also, Multicell Technology Patent Fa2n-4 is also sold by multiple companies and used at a couple universities in 2021. And Sekisui XenoTech is just one of them illegally licensing this product.

3) Sekisui XenoTech is selling Fa N2-4 Immortalized Human Hepatocytes for In Vitro Research and Drug Development with Multicell Technology permission.

Check them out here:

https://www.xenotech.com/in-vitro-test-systems/cell-products/primary-human-hepatocytes/plateable/immortalized/

4)
Multicell Technology Inc owns the patent Fa N2-4 cell line. And they aren't getting paid by Sekisui XenoTech.

5)
The reason why I know this is, I have been in contact with Multicell Technology and as of Dec of 2020 their Patent attorney paid the maintenance fee on this Fa N2-4 cell line and I also got them in contact with a bankruptcy attorney.

6)
Multicell Technology Inc Fa N2-4 Patent Information. Please check out the world wide application.

InventorJin LiuRonald A. Faris
Worldwide applications
2004 US AU JP EP WO EP CA AT CA US DE JP WO 2006 IL
Application PCT/US2004/033091 events
2003-10-10
Priority to US51050903P
2003-10-10
Priority to US60/510,509
2004-10-07
Application filed by Multicell Technologies, Inc.
2004-10-07
Priority claimed from AU2004322811A
2006-04-20
Publication of WO2006041488A1
2006-09-08
Publication of WO2006041488A8
InfoPatent citations (14) Non-patent citations (3) Cited by (10) Legal events Similar documents Priority and Related ApplicationsExternal linksEspacenetGlobal DossierPatentScopeDiscuss

US Patent Office Link:
https://patents.google.com/patent/WO2006041488A1/en


7)
MCETs: ADCETRIS® (brentuximab vedotin) for injection logo: Sold in 2021

COVID 19 RESPONSE BELOW:

This website is for US residents only.

ADCETRIS WEBSITE:
https://www.adcetris.com/


Check out Sec Link below.
MultiCell Technologies, Inc. - EX-99.1 - The MCIT Presentation by MultiCell Immunotherapeutics, Inc. was released on September 26, 2016. - September 26, 2016

SEC LINK:

https://fintel.io/doc/sec-mcet-multicell-technologies-ex991-2016-september-26-18384-918


8)
MCETs KADCYLA BREAST DRUG: Sold in 2021

COVID 19 response warning below:

Who is KADCYLA for?
Early Breast Cancer


MultiCell Technologies, Inc. - EX-99.1 - The MCIT Presentation by MultiCell Immunotherapeutics, Inc. was released on September 26, 2016. - September 26, 2016

SEC LINK:

https://fintel.io/doc/sec-mcet-multicell-technologies-ex991-2016-september-26-18384-918

KADCYLA Website:

https://fintel.io/doc/sec-mcet-multicell-technologies-ex991-2016-septem
ber-26-18384-918

9)
Personal, I think something is here, and people are making money,

( So laugh it up, but the joke won't be MCET or anyone investing and betting on them).

Considering it was at .0001 not to long ago and now it's at a steady .0004

We will see what happens by next year at this time?

Depending on where someone bought in so far, it's a 100 to 300 percent profit. I personally made money.

I will not be selling, this stock is a buy for me.